Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 1 |
| TOTAL | $N/A | $0 | $0 | $0 | $1 |
| Non-Current Assets | |||||
| Intangibles | 0 | 4 | 4 | 4 | 4 |
| TOTAL | $N/A | $4 | $4 | $4 | $4 |
| Total Assets | $0 | $4 | $4 | $4 | $5 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 32 | 110 | 12 | 12 | 15 |
| Accrued Expenses | 11 | N/A | 33 | 33 | 7 |
| Other current liabilities | 51 | N/A | 44 | 44 | 42 |
| TOTAL | $113 | $110 | $95 | $95 | $70 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $113 | $110 | $95 | $95 | $70 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,315 | N/A | 2,300 | 2,300 | 2,300 |
| Common Shares | 56 | 185 | N/A | N/A | 56 |
| Retained earnings | -377 | -370 | 207 | 207 | -329 |
| Other shareholders' equity | 0 | 0 | -343 | -343 | 1 |
| TOTAL | $-113 | $-106 | $-91 | $-91 | $-65 |
| Total Liabilities And Equity | $0 | $4 | $4 | $4 | $5 |